Giltuss EX Expectorant 600 mg/1
Giltuss EX Expectorant · TABLET · Gil Pharmaceutical Corp
Giltuss EX Expectorant is a tablet containing giltuss ex expectorant at 600 mg/1, taken oral. Manufactured by Gil Pharmaceutical Corp.
Key Facts
- Brand Name
- Giltuss EX Expectorant
- Generic Name
- Giltuss EX Expectorant
- NDC Code (Product)
58552-338- Manufacturer
- Gil Pharmaceutical Corp
- Strength
- 600 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- M012
- Drug Class
- Expectorant [EPC]
- Marketing Start
- 10/07/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and helps make cough more productive.
Dosage & Administration
Directions do not crush, chew, or break tablet take with a full glass of water this product can be administered without regard for the timing of meals adults and children 12 years of age and over: 1 or 2 tablets every 12 hours do not exceed 4 tablets in 24 hours children under 12 years of age: do not use
Warnings
Warnings Do not use for children under 12 years
Frequently Asked Questions
What is Giltuss EX Expectorant used for?
Giltuss EX Expectorant contains Giltuss EX Expectorant. It is a tablet taken oral. Consult your doctor for specific uses.
Is Giltuss EX Expectorant a controlled substance?
Giltuss EX Expectorant is not classified as a controlled substance by the DEA.
What is the generic name for Giltuss EX Expectorant?
The generic name for Giltuss EX Expectorant is Giltuss EX Expectorant. There are no other listed brand versions of Giltuss EX Expectorant.
What is the NDC code for Giltuss EX Expectorant 600 mg/1?
The NDC (National Drug Code) for Giltuss EX Expectorant 600 mg/1 is 58552-338, listed by Gil Pharmaceutical Corp.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)